Intrinsic Value of S&P & Nasdaq Contact Us

Lisata Therapeutics, Inc. LSTA

NASDAQ Capital Marke

SharesGrow Score
45/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Lisata Therapeutics, Inc. (LSTA) current share price is $4.01. The gold spot price is $4,825.20 per troy ounce. Using the formula: LSTA in gold = $4.01 × 31.1035 ÷ $4,825.20 = 0.0258 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of LSTA when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding LSTA shares over the measured period.

LSTA in US Dollars
Gold in US Dollars
LSTA in Gold (grams per share)

Real Wealth Growth Rate

LSTA
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{LSTA}_{\text{gold}}(t) = \frac{P_{\text{LSTA}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{LSTA}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{LSTA}_{\text{gold}}^{(T)}}{\text{LSTA}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{LSTA}_\text{gold}^{(0)}$ = initial gold-price, $\text{LSTA}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

ALPN
ALPN
Alpine Immune Sciences, Inc.
$64.97
+0.02%
GLUE
GLUE
Monte Rosa Therapeutics, Inc.
$18.23
+4.17%
CBIO
CBIO
Catalyst Biosciences, Inc.
$19.95
+2.20%
RZLT
RZLT
Rezolute, Inc.
$3.59
+1.13%
XOMAO
XOMAO
XOMA Corporation
$25.58
-1.06%
CADL
CADL
Candel Therapeutics, Inc.
$5.15
+0.98%
CYT
CYT
Cyteir Therapeutics, Inc.
$3.02
-2.27%
ANTX
ANTX
AN2 Therapeutics, Inc.
$3.26
+9.40%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message